BNP Paribas Financial Markets’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $92.8M | Buy |
1,026,122
+103,184
| +11% | +$8.64M | 0.03% | 476 |
|
|
2026
Q1 | $73.9M | Buy |
922,938
+323,482
| +54% | +$26.7M | 0.04% | 519 |
|
|
2025
Q4 | $51.1M | Buy |
599,456
+92,641
| +18% | +$7.6M | 0.02% | 676 |
|
|
2025
Q3 | $39.4M | Sell |
506,815
-542,107
| -52% | -$42.4M | 0.02% | 739 |
|
|
2025
Q2 | $82M | Sell |
1,048,922
-897,896
| -46% | -$67M | 0.05% | 389 |
|
|
2025
Q1 | $141M | Buy |
1,946,818
+525,849
| +37% | +$37.6M | 0.08% | 250 |
|
|
2024
Q4 | $105M | Sell |
1,420,969
-61,337
| -4% | -$4.29M | 0.06% | 332 |
|
|
2024
Q3 | $97.8M | Buy |
1,482,306
+488,201
| +49% | +$35.5M | 0.07% | 284 |
|
|
2024
Q2 | $91.8M | Buy |
994,105
+115,565
| +13% | +$10.2M | 0.07% | 258 |
|
|
2024
Q1 | $84M | Buy |
878,540
+398,701
| +83% | +$33.5M | 0.07% | 288 |
|
|
2023
Q4 | $36.6M | Sell |
479,839
-234,173
| -33% | -$16.3M | 0.04% | 473 |
|
|
2023
Q3 | $49.5M | Buy |
714,012
+152,898
| +27% | +$12.3M | 0.06% | 303 |
|
|
2023
Q2 | $52.9M | Buy |
561,114
+220,238
| +65% | +$19.1M | 0.07% | 279 |
|
|
2023
Q1 | $28.2M | Sell |
340,876
-3,821
| -1% | -$300K | 0.04% | 468 |
|
|
2022
Q4 | $25.7M | Sell |
344,697
-61,882
| -15% | -$4.77M | 0.04% | 552 |
|
|
2022
Q3 | $33.6M | Sell |
406,579
-61,254
| -13% | -$5.89M | 0.05% | 407 |
|
|
2022
Q2 | $44.5M | Sell |
467,833
-93,474
| -17% | -$9.68M | 0.07% | 309 |
|
|
2022
Q1 | $66.1M | Buy |
561,307
+92,159
| +20% | +$10.3M | 0.09% | 231 |
|
|
2021
Q4 | $60.8M | Sell |
469,148
-27,276
| -5% | -$3.18M | 0.09% | 252 |
|
|
2021
Q3 | $56.2M | Buy |
496,424
+129,916
| +35% | +$14.8M | 0.08% | 272 |
|
|
2021
Q2 | $38M | Buy |
366,508
+67,183
| +22% | +$6.33M | 0.05% | 399 |
|
|
2021
Q1 | $25M | Buy |
299,325
+8,824
| +3% | +$746K | 0.04% | 471 |
|
|
2020
Q4 | $26.5M | Sell |
290,501
-75,731
| -21% | -$6.28M | 0.05% | 387 |
|
|
2020
Q3 | $29.2M | Buy |
366,232
+134,259
| +58% | +$10.5M | 0.04% | 403 |
|
|
2020
Q2 | $16M | Sell |
231,973
-99,497
| -30% | -$7.07M | 0.03% | 539 |
|
|
2020
Q1 | $20.8M | Buy |
331,470
+161,259
| +95% | +$11.6M | 0.04% | 393 |
|
|
2019
Q4 | $13.2M | Buy |
170,211
+24,492
| +17% | +$1.91M | 0.02% | 681 |
|
|
2019
Q3 | $10.7M | Sell |
145,719
-8,139
| -5% | -$572K | 0.02% | 747 |
|
|
2019
Q2 | $9.47M | Buy |
153,858
+40,422
| +36% | +$2.44M | 0.02% | 752 |
|
|
2019
Q1 | $7.23M | Buy |
113,436
+24,732
| +28% | +$1.41M | 0.02% | 828 |
|
|
2018
Q4 | $4.53M | Sell |
88,704
-126,654
| -59% | -$6.41M | 0.01% | 953 |
|
|
2018
Q3 | $12.5M | Sell |
215,358
-60,948
| -22% | -$2.98M | 0.02% | 745 |
|
|
2018
Q2 | $13.4M | Buy |
276,306
+167,046
| +153% | +$7.8M | 0.02% | 675 |
|
|
2018
Q1 | $5.08M | Sell |
109,260
-51,825
| -32% | -$2.25M | 0.01% | 987 |
|
|
2017
Q4 | $6.05M | Sell |
161,085
-251,127
| -61% | -$9.22M | 0.01% | 948 |
|
|
2017
Q3 | $15M | Buy |
412,212
+125,082
| +44% | +$4.77M | 0.04% | 440 |
|
|
2017
Q2 | $11.3M | Sell |
287,130
-114,288
| -28% | -$4.17M | 0.03% | 488 |
|
|
2017
Q1 | $12.6M | Buy |
401,418
+269,004
| +203% | +$8.42M | 0.03% | 517 |
|
|
2016
Q4 | $4.14M | Buy |
132,414
+108,162
| +446% | +$3.5M | 0.02% | 630 |
|
|
2016
Q3 | $975K | Sell |
24,252
-31,080
| -56% | -$1.17M | ﹤0.01% | 934 |
|
|
2016
Q2 | $1.84M | Sell |
55,332
-277,662
| -83% | -$9.5M | 0.01% | 895 |
|
|
2016
Q1 | $9.79M | Buy |
332,994
+292,587
| +724% | +$8.07M | 0.04% | 370 |
|
|
2015
Q4 | $1.06M | Sell |
40,407
-507,489
| -93% | -$13.2M | ﹤0.01% | 1095 |
|
|
2015
Q3 | $13M | Buy |
547,896
+466,794
| +576% | +$11.3M | 0.03% | 350 |
|
|
2015
Q2 | $1.93M | Sell |
81,102
-19,926
| -20% | -$450K | 0.01% | 881 |
|
|
2015
Q1 | $2.4M | Sell |
101,028
-206,814
| -67% | -$4.64M | 0.01% | 837 |
|
|
2014
Q4 | $6.54M | Sell |
307,842
-4,866
| -2% | -$97.8K | 0.02% | 562 |
|
|
2014
Q3 | $5.32M | Buy |
312,708
+83,526
| +36% | +$1.32M | ﹤0.01% | 706 |
|
|
2014
Q2 | $3.28M | Sell |
229,182
-30,492
| -12% | -$413K | ﹤0.01% | 800 |
|
|
2014
Q1 | $3.53M | Sell |
259,674
-89,448
| -26% | -$1.03M | ﹤0.01% | 754 |
|
|
2013
Q4 | $3.83M | Sell |
349,122
-35,652
| -9% | -$402K | ﹤0.01% | 714 |
|
|
2013
Q3 | $4.47M | Buy |
384,774
+364,164
| +1,767% | +$4.26M | ﹤0.01% | 737 |
|
|
2013
Q2 | $231K | Buy |
+20,610
| New | +$244K | ﹤0.01% | 2218 |
|
Other funds holding EW
VCM
VPM
BNP Paribas Financial Markets's EW Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Edwards Lifesciences (EW) stake by 11% in Q2 2026, buying an estimated $8.64M and bringing the position to 1,026,122 shares worth $92.8M. The position accounts for 0.03% of the portfolio, ranked #476.
BNP Paribas Financial Markets first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $141M in Q1 2025. 1,096 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- BNP Paribas Financial Markets held 1,026,122 shares of Edwards Lifesciences worth $92.8M as of Q2 2026.
- BNP Paribas Financial Markets bought 103,184 Edwards Lifesciences shares in Q2 2026, an estimated $8.64M.
- Edwards Lifesciences made up 0.03% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #476 holding.
- BNP Paribas Financial Markets first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- BNP Paribas Financial Markets's Edwards Lifesciences position peaked at $141M in Q1 2025.
- 1,096 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.